Pre-natal folic acid and iron supplementation and atopic dermatitis in the first 6 years of life
- 68 Downloads
Exposure in utero has been suggested to influence health later in life. The aim of this study was to investigate, if the use of prenatal food supplements was associated with atopic dermatitis in the offspring. Mothers who gave birth in the hospital G. B. Grassi were invited to participate in the study (n = 395). Information on socio-demographic characteristics, clinical data of the mothers and babies, vegetables and fruit intake, food avoidance, and food supplements use during pregnancy, depression status, and environmental exposure was obtained for all subjects in the hospital at the time of delivery. Data on breastfeeding practice, introduction of weaning foods, day care attendance, and atopic dermatitis were collected in the postnatal follow-ups. Logistic regression was applied to estimate odds ratio (OR) and 95% confidence intervals (CI). Children in which mothers used both iron and folic acid supplementation had a fourfold decreased risk of developing atopic dermatitis [OR = 0.22; 95% confidence interval (CI) 0.06–0.79, p = 0.02], after adjusting for possible confounding factors. Findings suggest an independent and protective effect of prenatal folic acid and iron supplementation for atopic dermatitis in children.
KeywordsAtopic dermatitis Risk factors Folic acid and iron supplementation
This work was supported by the Lazio Regional Health Authority and by the Progetto di Ricerca 4.2, Atopic Dermatitis, Italian Ministry of Heath, 2018.
Compliance with ethical standards
Conflict of interest
The authors declared that they have no conflicts of interest to disclose.
Informed consensus was obtained from all participants of the study.
- 2.Brunner PM, Silverberg JI, Guttman-Yassky E, Paller AS, Kabashima K, Amagai M, Luger TA, Deleuran M, Werfel T, Eyerich K, Stingl G (2017) Increasing comorbidities suggest that atopic dermatitis is a systemic disorder. J Invest Dermatol 137:18–25. https://doi.org/10.1016/j.jid.2016.08.022 CrossRefGoogle Scholar
- 6.Deckers IA, McLean S, Linssen S, Mommers M, van Schayck CP, Sheikh A (2012) Investigating international time trends in the incidence and prevalence of atopic eczema 1990–2010: a systematic review of epidemiological studies. PLoS One 7:e39803. https://doi.org/10.1371/journal.pone.0039803 CrossRefGoogle Scholar
- 7.Dom S, Droste JH, Sariachvili MA, Hagendorens MM, Oostveen E, Bridts CH, Stevens WJ, Wieringa MH, Weyler JJ (2010) Pre- and post-natal exposure to antibiotics and the development of eczema, recurrent wheezing and atopic sensitization in children up to the age of 4 years. Clin Exp Allergy 40:1378–1387. https://doi.org/10.1111/j.1365-2222.2010.03538.x CrossRefGoogle Scholar
- 8.Dunstan JA, West C, McCarthy S, Metcalfe J, Meldrum S, Oddy WH, Tulic MK, D’Vaz N, Prescott SL (2012) The relationship between maternal folate status in pregnancy, cord blood folate levels, and allergic outcomes in early childhood. Allergy 67:50–57. https://doi.org/10.1111/j.1398-9995.2011.02714.x CrossRefGoogle Scholar
- 11.Karimkhani C, Dellavalle RP, Coffeng LE, Flohr C, Hay RJ, Langan SM, Nsoesie EO, Ferrari AJ, Erskine HE, Silverberg JI, Vos T, Naghavi M (2017) Global skin disease morbidity and mortality: an update from the global burden of disease study 2013. JAMA Dermatol 153:406–412. https://doi.org/10.1001/jamadermatol.2016.5538 CrossRefGoogle Scholar
- 12.Kim JH, Jeong KS, Ha EH, Park H, Ha M, Hong YC, Bhang SY, Lee SJ, Lee KY, Lee SH, Kim Y, Kim MH, Chang N (2015) Relationship between prenatal and postnatal exposures to folate and risks of allergic and respiratory diseases in early childhood. Pediatr Pulmonol 50:155–163. https://doi.org/10.1002/ppul.23025 CrossRefGoogle Scholar
- 18.Richmond RC, Sharp GC, Herbert G, Atkinson C, Taylor C, Bhattacharya S, Campbell D, Hall M, Kazmi N, Gaunt T, McArdle W, Ring S, Davey Smith G, Ness A, Relton CL (2018) The long-term impact of folic acid in pregnancy on offspring DNA methylation: follow-up of the Aberdeen Folic Acid Supplementation Trial (AFAST). Int J Epidemiol. https://doi.org/10.1093/ije/dyy032 Google Scholar